Thin-section CT follow-up of metastatic ovarian carcinoma correlation with levels of CA-125 marker and clinical history

Francesco Ferrozzi, Davide Bova, Flavia De Chiara, Giacomo Garlaschi, Ferdinando Draghi, Giovanni Cocconi, Pellegrino Bassi

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Second-look laparotomy and CA-125 are the gold standard in follow-up of ovarian carcinoma. Since no definite role seems established for cross-sectional imaging in assessment of recurrence we employed thin-section computed tomography (CT), correlated with CA-125 levels and detailed knowledge of the clinical history as a follow-up protocol. One hundred seventy-seven patients with ovarian carcinoma were selected because of: (a) pathologically proven remission after first-line chemotherapy, (b) follow-up by means of thin-section CT every 6 months for the first 3 years and every 10 months subsequently, (c) monitoring CA-125 serum levels every 3 months for the first 3 years and every 6 months subsequently; (d) pathologic confirmation or clinical and laboratory follow-up after 12 months or longer from the CT findings. Fifty percent of the patients showed recurrence of disease. Our protocol yielded 93.2% true positive, dubious findings in 5.6%, 1.0% false negatives, 97.7% true negatives, and 2.3% false positive. With a tailored technique, CT was particularly sensitive in early diagnosis of peritoneal seeding, even in the absence of ascites or increases in the levels of CA-125. Repeated administration of contrast medium, water enemas, and repeated scanning of suspicious volumes with differing scanning parameters were the factors managed by the radiologist. We conclude that thin-section CT, correlated with CA-125 levels and careful review of the clinical history could represent a valid alternative to repeated explorative laparotomies in the follow-up of ovarian carcinomas.

Original languageEnglish
Pages (from-to)364-370
Number of pages7
JournalClinical Imaging
Volume22
Issue number5
DOIs
Publication statusPublished - Sep 1998

Fingerprint

Biomarkers
Tomography
Carcinoma
Laparotomy
Recurrence
Enema
Ascites
Contrast Media
Early Diagnosis
Drug Therapy
Water
Serum

Keywords

  • Metastases
  • Neoplasms
  • Ovary
  • Peritoneum
  • Staging

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

Thin-section CT follow-up of metastatic ovarian carcinoma correlation with levels of CA-125 marker and clinical history. / Ferrozzi, Francesco; Bova, Davide; De Chiara, Flavia; Garlaschi, Giacomo; Draghi, Ferdinando; Cocconi, Giovanni; Bassi, Pellegrino.

In: Clinical Imaging, Vol. 22, No. 5, 09.1998, p. 364-370.

Research output: Contribution to journalArticle

Ferrozzi, Francesco ; Bova, Davide ; De Chiara, Flavia ; Garlaschi, Giacomo ; Draghi, Ferdinando ; Cocconi, Giovanni ; Bassi, Pellegrino. / Thin-section CT follow-up of metastatic ovarian carcinoma correlation with levels of CA-125 marker and clinical history. In: Clinical Imaging. 1998 ; Vol. 22, No. 5. pp. 364-370.
@article{8c5259dd6bdd4b0a96bd77301fd670a8,
title = "Thin-section CT follow-up of metastatic ovarian carcinoma correlation with levels of CA-125 marker and clinical history",
abstract = "Second-look laparotomy and CA-125 are the gold standard in follow-up of ovarian carcinoma. Since no definite role seems established for cross-sectional imaging in assessment of recurrence we employed thin-section computed tomography (CT), correlated with CA-125 levels and detailed knowledge of the clinical history as a follow-up protocol. One hundred seventy-seven patients with ovarian carcinoma were selected because of: (a) pathologically proven remission after first-line chemotherapy, (b) follow-up by means of thin-section CT every 6 months for the first 3 years and every 10 months subsequently, (c) monitoring CA-125 serum levels every 3 months for the first 3 years and every 6 months subsequently; (d) pathologic confirmation or clinical and laboratory follow-up after 12 months or longer from the CT findings. Fifty percent of the patients showed recurrence of disease. Our protocol yielded 93.2{\%} true positive, dubious findings in 5.6{\%}, 1.0{\%} false negatives, 97.7{\%} true negatives, and 2.3{\%} false positive. With a tailored technique, CT was particularly sensitive in early diagnosis of peritoneal seeding, even in the absence of ascites or increases in the levels of CA-125. Repeated administration of contrast medium, water enemas, and repeated scanning of suspicious volumes with differing scanning parameters were the factors managed by the radiologist. We conclude that thin-section CT, correlated with CA-125 levels and careful review of the clinical history could represent a valid alternative to repeated explorative laparotomies in the follow-up of ovarian carcinomas.",
keywords = "Metastases, Neoplasms, Ovary, Peritoneum, Staging",
author = "Francesco Ferrozzi and Davide Bova and {De Chiara}, Flavia and Giacomo Garlaschi and Ferdinando Draghi and Giovanni Cocconi and Pellegrino Bassi",
year = "1998",
month = "9",
doi = "10.1016/S0899-7071(98)00023-0",
language = "English",
volume = "22",
pages = "364--370",
journal = "Clinical Imaging",
issn = "0899-7071",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - Thin-section CT follow-up of metastatic ovarian carcinoma correlation with levels of CA-125 marker and clinical history

AU - Ferrozzi, Francesco

AU - Bova, Davide

AU - De Chiara, Flavia

AU - Garlaschi, Giacomo

AU - Draghi, Ferdinando

AU - Cocconi, Giovanni

AU - Bassi, Pellegrino

PY - 1998/9

Y1 - 1998/9

N2 - Second-look laparotomy and CA-125 are the gold standard in follow-up of ovarian carcinoma. Since no definite role seems established for cross-sectional imaging in assessment of recurrence we employed thin-section computed tomography (CT), correlated with CA-125 levels and detailed knowledge of the clinical history as a follow-up protocol. One hundred seventy-seven patients with ovarian carcinoma were selected because of: (a) pathologically proven remission after first-line chemotherapy, (b) follow-up by means of thin-section CT every 6 months for the first 3 years and every 10 months subsequently, (c) monitoring CA-125 serum levels every 3 months for the first 3 years and every 6 months subsequently; (d) pathologic confirmation or clinical and laboratory follow-up after 12 months or longer from the CT findings. Fifty percent of the patients showed recurrence of disease. Our protocol yielded 93.2% true positive, dubious findings in 5.6%, 1.0% false negatives, 97.7% true negatives, and 2.3% false positive. With a tailored technique, CT was particularly sensitive in early diagnosis of peritoneal seeding, even in the absence of ascites or increases in the levels of CA-125. Repeated administration of contrast medium, water enemas, and repeated scanning of suspicious volumes with differing scanning parameters were the factors managed by the radiologist. We conclude that thin-section CT, correlated with CA-125 levels and careful review of the clinical history could represent a valid alternative to repeated explorative laparotomies in the follow-up of ovarian carcinomas.

AB - Second-look laparotomy and CA-125 are the gold standard in follow-up of ovarian carcinoma. Since no definite role seems established for cross-sectional imaging in assessment of recurrence we employed thin-section computed tomography (CT), correlated with CA-125 levels and detailed knowledge of the clinical history as a follow-up protocol. One hundred seventy-seven patients with ovarian carcinoma were selected because of: (a) pathologically proven remission after first-line chemotherapy, (b) follow-up by means of thin-section CT every 6 months for the first 3 years and every 10 months subsequently, (c) monitoring CA-125 serum levels every 3 months for the first 3 years and every 6 months subsequently; (d) pathologic confirmation or clinical and laboratory follow-up after 12 months or longer from the CT findings. Fifty percent of the patients showed recurrence of disease. Our protocol yielded 93.2% true positive, dubious findings in 5.6%, 1.0% false negatives, 97.7% true negatives, and 2.3% false positive. With a tailored technique, CT was particularly sensitive in early diagnosis of peritoneal seeding, even in the absence of ascites or increases in the levels of CA-125. Repeated administration of contrast medium, water enemas, and repeated scanning of suspicious volumes with differing scanning parameters were the factors managed by the radiologist. We conclude that thin-section CT, correlated with CA-125 levels and careful review of the clinical history could represent a valid alternative to repeated explorative laparotomies in the follow-up of ovarian carcinomas.

KW - Metastases

KW - Neoplasms

KW - Ovary

KW - Peritoneum

KW - Staging

UR - http://www.scopus.com/inward/record.url?scp=0031718822&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031718822&partnerID=8YFLogxK

U2 - 10.1016/S0899-7071(98)00023-0

DO - 10.1016/S0899-7071(98)00023-0

M3 - Article

VL - 22

SP - 364

EP - 370

JO - Clinical Imaging

JF - Clinical Imaging

SN - 0899-7071

IS - 5

ER -